Verstovsek, S., Chen, C., Egyed, M., Ellis, M., Fox, L., Goh, Y., . . . Mesa, R. (2021). MOMENTUM: Momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemic. Future Medicine.
শিকাগো স্টাইল (17 তম সংস্করণ) উদ্ধৃতিVerstovsek, S., et al. MOMENTUM: Momelotinib Vs Danazol in Patients with Myelofibrosis Previously Treated with JAKi Who Are Symptomatic and Anemic. Future Medicine, 2021.
M.L.A (9 ম সংস্করণ) উদ্ধৃতিVerstovsek, S., et al. MOMENTUM: Momelotinib Vs Danazol in Patients with Myelofibrosis Previously Treated with JAKi Who Are Symptomatic and Anemic. Future Medicine, 2021.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.